This condition of systemic inflammation, characterized by elevated levels of proinflammatory (i.e., TNF-α, IL-1β, IL-6) and immunoregulatory cytokines (i.e., IL-10) persists in CVID subjects despite receiving adequate IgG replacement therapy. This evidence concerns the gene IL10 and common variable immunodeficiency.